cT2N0 esophageal adenocarcinoma: predictors of lymph nodal involvement and clinical significance.
作者信息
Singhal Saurabh, Roy Soumen
机构信息
Department of GI Surgery and Liver Transplantation, Indraprastha Apollo Hospital, New Delhi, India.
出版信息
J Thorac Dis. 2019 Mar;11(Suppl 3):S453-S456. doi: 10.21037/jtd.2018.11.24.
Abstract
摘要
相似文献
1
cT2N0 esophageal adenocarcinoma: predictors of lymph nodal involvement and clinical significance.cT2N0期食管腺癌：淋巴结受累的预测因素及临床意义。
J Thorac Dis. 2019 Mar;11(Suppl 3):S453-S456. doi: 10.21037/jtd.2018.11.24.
2
Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.临床 T2N0 食管腺癌淋巴结转移的预测因素。
Ann Thorac Surg. 2018 Jul;106(1):172-177. doi: 10.1016/j.athoracsur.2018.02.087. Epub 2018 Apr 5.
3
Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.胃食管结合部腺癌与累及胃食管结合部的下段食管鳞癌纵隔淋巴结转移的比较。
Dis Esophagus. 2019 Dec 30;32(11). doi: 10.1093/dote/doz002.
4
Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.接受三联疗法的食管腺癌患者的生存率与区域淋巴结位置无关。
Ann Thorac Surg. 2016 Mar;101(3):1075-80; Discussion 1080-1. doi: 10.1016/j.athoracsur.2015.09.063. Epub 2015 Dec 8.
5
Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.临床 T2-T3N0M0 食管癌：淋巴结阳性疾病的风险。
Ann Thorac Surg. 2011 Aug;92(2):491-6; discussion 496-8. doi: 10.1016/j.athoracsur.2011.04.004. Epub 2011 Jun 24.
6
Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.早期食管腺癌患者的治疗分配：淋巴结受累的患病率及预测因素
Cancer. 2016 Jul 15;122(14):2150-7. doi: 10.1002/cncr.30040. Epub 2016 May 3.
7
Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.胸段食管鳞状细胞癌的淋巴结跳跃转移：一项队列研究。
BMC Surg. 2017 May 2;17(1):49. doi: 10.1186/s12893-017-0247-5.
8
Significance of lymph nodal metastases in treatment of esophagogastric adenocarcinoma.淋巴结转移在食管胃腺癌治疗中的意义
Lymphology. 1992 Mar;25(1):31-6.
9
Proposed modification of nodal status in AJCC esophageal cancer staging system.美国癌症联合委员会（AJCC）食管癌分期系统中淋巴结状态的拟议修改。
Ann Thorac Surg. 2007 Aug;84(2):365-73; discussion 374-5. doi: 10.1016/j.athoracsur.2007.01.067.
10
Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?对于 cT2N0 期食管鳞癌，是否应尝试内镜黏膜下剥离术？
Dis Esophagus. 2019 Dec 13;32(10):1-6. doi: 10.1093/dote/doz016.
引用本文的文献
1
Esophageal cancer: challenges, concerns, and recommendations for management amidst the COVID-19 pandemic.食管癌：2019冠状病毒病大流行期间的挑战、关切及管理建议
Ann Gastroenterol. 2020 Sep-Oct;33(5):453-458. doi: 10.20524/aog.2020.0519. Epub 2020 Jun 22.
本文引用的文献
1
Quality of life after esophageal resection.食管切除术后的生活质量。
Patient Relat Outcome Meas. 2018 Apr 4;9:137-146. doi: 10.2147/PROM.S150180. eCollection 2018.
2
Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.临床 T2N0 食管腺癌淋巴结转移的预测因素。
Ann Thorac Surg. 2018 Jul;106(1):172-177. doi: 10.1016/j.athoracsur.2018.02.087. Epub 2018 Apr 5.
3
New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.指导食管胃交界部肿瘤淋巴结清扫范围的新证据：Ber-Ep4联合CD44v6染色在检测下纵隔淋巴结微转移中的应用及生存分析
Medicine (Baltimore). 2017 Apr;96(14):e6533. doi: 10.1097/MD.0000000000006533.
4
Analysis of Predictors for Lymph Node Metastasis in Patients with Superficial Esophageal Carcinoma.浅表性食管癌患者淋巴结转移的预测因素分析
Gastroenterol Res Pract. 2016;2016:3797615. doi: 10.1155/2016/3797615. Epub 2016 Oct 5.
5
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.新辅助放化疗联合手术与单纯手术治疗食管或食管胃交界癌（CROSS）：一项随机对照临床试验的长期结果。
Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
6
Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.手术切除的T1期食管癌淋巴结转移的预测因素
Ann Thorac Surg. 2015 Jun;99(6):1879-85; discussion 1886. doi: 10.1016/j.athoracsur.2015.02.112. Epub 2015 Apr 28.
7
Sentinel lymph node biopsy in esophageal cancer: an essential step towards individualized care.食管癌前哨淋巴结活检：迈向个体化治疗的关键一步。
Ann Surg Innov Res. 2014 May 5;8:2. doi: 10.1186/1750-1164-8-2. eCollection 2014.
8
Prognostic risk factors of early esophageal adenocarcinomas.早期食管腺癌的预后危险因素。
Ann Surg. 2014 Mar;259(3):469-76. doi: 10.1097/SLA.0000000000000217.
9
Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.评估 T2N0 期食管癌临床分期的可靠性：胸外科医师学会数据库的回顾性研究。
Ann Thorac Surg. 2013 Aug;96(2):382-90. doi: 10.1016/j.athoracsur.2013.03.093. Epub 2013 May 31.
10
Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: results from a referral center for early esophageal cancer.内镜超声检查在食管癌术前分期中的准确性：来自早期食管癌转诊中心的结果。
Endoscopy. 2010 Jun;42(6):456-61. doi: 10.1055/s-0029-1244022. Epub 2010 Mar 19.
Zotero 插件